Skip to main content
Log in

Local low-dose urokinase treatment of acquired intracardiac thrombi in preterm infants

  • CARDIOLOGY
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

We report three cases of intracardiac thrombi in preterm infants of very low birth weight, in whom local low-dose urokinase treatment achieved complete thrombolysis without any signs of systemic fibrinolytic activity or side-effects.

Conclusion This new treatment strategy seems to be safe, requires minimal monitoring of fibrinolytic activity, and may be a new option for thrombolysis in high-risk patients such as premature infants, patients recently operated on, and patients presenting with other contra-indications for systemic fibrinolytic therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 4 November 1998 / Accepted in revised form: 5 February 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aspesberro, F., Beghetti, M., Oberhänsli, I. et al. Local low-dose urokinase treatment of acquired intracardiac thrombi in preterm infants. Eur J Pediatr 158, 698–701 (1999). https://doi.org/10.1007/s004310051182

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004310051182

Navigation